This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Management of a Patient With Facial Redness Plus Papulopustular Lesions

Management of a Patient With Facial Redness Plus Papulopustular Lesions

Format

Patient Case Study

Time to Complete

1 hour

Released

April 7, 2017

Expires

April 7, 2018
Add to Queue


Maximum Credits

1.00 / AMA PRA Category 1 CreditTM

Accredited Provider



Provided by Haymarket Medical Education

Commercial Supporter

Supported by an educational grant from Allergan

Partner



In partnership with the National Rosacea Society

Program Description

A growing understanding of rosacea pathophysiology and the emergence of treatments that target specific manifestations of the disorder, including persistent facial erythema, are advancing the quality of care. A clearer sense of diagnostic criteria and the advantages and limitations of the scope of therapies is essential so dermatologists and other clinicians who manage patients with rosacea can devise treatment plans that are tailored to the pattern and severity of individual patients’ symptoms across the rosacea spectrum.

This Case Clinic, which focuses on the management of a patient who presents with facial redness plus papulopustular lesions, is the first in a series of 3 illustrating different clinical challenges in rosacea management that together fulfill the educational objectives outlined below. We urge you to complete all 3 case activities for the most complete educational experience.

Intended Audience

Dermatologists and other healthcare professionals who provide care for patients with rosacea

Educational Objectives

At the conclusion of this activity, participants should be better able to:

  • Describe current theories of the pathophysiology of rosacea
  • Identify the spectrum of clinical signs and symptoms of rosacea, including its characteristic persistent facial erythema
  • Assess the risks, benefits, safety profile, and limitations of current and emerging treatments for rosacea
  • Individualize rosacea treatment plans according to specific manifestations, symptom severity, and other patient characteristics
  • Counsel and educate patients with rosacea to ensure correct and consistent adherence to treatment recommendations

Conflict Of Interest Disclosure Policy

In accordance with the ACCME Standards for Commercial Support, HME requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. HME resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

Faculty

ACTIVITY CHAIR
James Q. Del Rosso, DO, FAOCD

Adjunct Clinical Professor (Dermatology)
Touro University Nevada
Henderson, NV
Research Director / Clinical Dermatology
JDR Dermatology Research /Thomas Dermatology
Las Vegas, NV

Dr. Del Rosso discloses the receipt of consulting, speaker’s bureau and/or contracted research fees from the following: Allergan, Aqua/Almirall, Bayer, BiopharmX, Celgene, Cutanea, Dermira, Ferndale, Foamix, Galderma, Genentech, LEO Pharma, Novan, Novartis, Pfizer, Promius, Sebacia, Sun Pharma, Unilever, and Valeant.

FACULTY
Diane S. Berson, MD, FAAD

Associate Clinical Professor of Dermatology
Weill Medical College of Cornell University
New York-Presbyterian Hospital
New York, NY

Dr. Berson discloses the receipt of consulting, speaker's bureau, and/or contracted research fees for the following: Aclaris Therapeutics Inc., Allergan, Bayer Pharmaceuticals Company, Ferndale Pharma Group; Galderma, Johnson & Johnson, P & G Dermatology, SkinFix, Inc., and Valeant Pharmaceuticals International.

Accredited Provider Disclosure

Haymarket Medical Education staff involved in the planning and content review of this activity have no relevant financial relationships to disclose.

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

Haymarket Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement

Haymarket Medical Education designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Unlabeled Use

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient’s medical condition.

Disclaimer

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Haymarket Medical Education, the National Rosacea Society, and Allergan. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

If you have any questions relating to the accreditation of this activity, please contact cmequestions@haymarketmedical.com.

Instructions

To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

Privacy Policy

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue